Pyxis Oncology Insider Trades
NASDAQ: PYXSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Pre-market: 2.03 0.00%
Last 12 months
- Purchases
- 1 · $0
- Sales
- 1 · $107.10K
- Shares bought / sold
- 5.52M / 35.00K
- Net activity
- Net selling $107,100
Pyxis Oncology insider activity
Over the last 12 months, Pyxis Oncology insiders reported 4 transactions on SEC Form 4: 1 open-market purchase and 1 sale. Insiders bought $0 and sold $107,100 worth of stock, for net insider selling of $107,100. The largest seller was Dupont Jakob, with $107,100 in reported sales.
The most recent filing shows GordonMD Global Investments LP & GordonMD Long Biased Master Fund LP & GordonMD Long Biased GP LLC & Gordon Craig D (10% Owner) buying 5,517,000 shares on Oct 1, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put PYXS's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
PYXS insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Oct 1, 2026 | GordonMD Global Investments LP & GordonMD Long Biased Master Fund LP & GordonMD Long Biased GP LLC & Gordon Craig D10% Owner | Buy | 5,517,000 | — | Form 4 |
| Jun 30, 2026 | Dupont JakobDirector | Sale | 35,000 | $107.10K | Form 4 |
| Jun 30, 2026 | Dupont JakobDirector | Option exercise | 35,000 | $56.00K | Form 4 |
| Mar 24, 2026 | Wadhane JitendraPrin Fin & Acct Officer | Award | 109,461 | — | Form 4 |
| Apr 21, 2025 | HUMPHREY RACHELDirector | Sale | 13,896 | $14.36K | Form 4 |
| Apr 17, 2025 | HUMPHREY RACHELDirector | Sale | 200 | $194 | Form 4 |
| Apr 14, 2025 | HUMPHREY RACHELDirector | Sale | 1,400 | $1.36K | Form 4 |
| Nov 26, 2024 | Connealy Pamela AnnCFO & COO | Buy | 83,400 | $163.46K | Form 4 |
| Nov 26, 2024 | Connealy Pamela AnnCFO & COO | Buy | 5,450 | $10.90K | Form 4 |
| Jun 7, 2024 | Palani SanthoshDirector | Award | 6,000 | — | Form 4 |
| Mar 26, 2024 | HUMPHREY RACHELDirector | Award | 38,741 | — | Form 4 |
| Mar 26, 2024 | FLAVIN JOHN LDirector | Award | 35,219 | — | Form 4 |
| Mar 26, 2024 | Connealy Pamela AnnCFO & COO | Award | 328,710 | — | Form 4 |
| Mar 26, 2024 | Lewis-Hall Freda CDirector | Award | 35,219 | — | Form 4 |
| Mar 26, 2024 | Dupont JakobDirector | Award | 38,741 | — | Form 4 |
| Mar 26, 2024 | Cline Darren SDirector | Award | 35,219 | — | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4